Natixis’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,041
| Closed | -$44.1K | – | 1081 |
|
|
2022
Q4 | $44.1K | Buy |
+3,041
| New | +$44.1K | ﹤0.01% | 868 |
|
|
2022
Q1 | – | Sell |
-13,450
| Closed | -$371K | – | 1268 |
|
|
2021
Q4 | $371K | Sell |
13,450
-15,933
| -54% | -$439K | ﹤0.01% | 1090 |
|
|
2021
Q3 | $949K | Buy |
29,383
+22,383
| +320% | +$723K | ﹤0.01% | 902 |
|
|
2021
Q2 | $214K | Hold |
7,000
| – | – | ﹤0.01% | 813 |
|
|
2021
Q1 | $213K | Buy |
+7,000
| New | +$213K | ﹤0.01% | 1022 |
|
|
2018
Q4 | – | Sell |
-10,230
| Closed | -$471K | – | 781 |
|
|
2018
Q3 | $471K | Buy |
10,230
+4,123
| +68% | +$190K | ﹤0.01% | 636 |
|
|
2018
Q2 | $228K | Buy |
+6,107
| New | +$228K | ﹤0.01% | 802 |
|
|
2014
Q1 | – | Sell |
-105,321
| Closed | -$2.21M | – | 572 |
|
|
2013
Q4 | $2.21M | Buy |
105,321
+66,144
| +169% | +$1.39M | 0.02% | 284 |
|
|
2013
Q3 | $921K | Buy |
39,177
+14,655
| +60% | +$345K | 0.01% | 328 |
|
|
2013
Q2 | $659K | Buy |
+24,522
| New | +$659K | 0.01% | 313 |
|